| Income Statement |
| Operating Expenses | 5.09M |
|
| Research and Development Expense | 2.33M |
| Selling, General and Administrative Expense | 2.76M |
| Operating Income | -5.09M |
| Net Income | -5.04M |
| Net Income Common Stock | -5.04M |
| Net Income Common Stock (USD) | -5.04M |
| Consolidated Income | -5.04M |
| Earnings per Basic Share | -0.10 |
| Earnings per Basic Share (USD) | -0.10 |
| Earnings per Diluted Share | -0.10 |
| Earning Before Interest & Taxes (EBIT) | -5.04M |
| Earning Before Interest & Taxes (USD) | -5.04M |
| Weighted Average Shares | 52.77M |
| Weighted Average Shares Diluted | 52.77M |
| Balance Sheet |
| Cash and Equivalents | 8.72M |
| Cash and Equivalents (USD) | 8.72M |
| Current Assets | 9.00M |
| Property, Plant & Equipment Net | 1.58M |
| Total Assets | 10.64M |
| Current Liabilities | 2.46M |
| Total Liabilities | 2.46M |
| Accumulated Retained Earnings (Deficit) | -87.03M |
| Shareholders Equity | 8.18M |
| Shareholders Equity (USD) | 8.18M |
| Assets Non-Current | 1.64M |
| Inventory | 110.00K |
| Trade and Non-Trade Payables | 608.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 57.00K |
| Net Cash Flow from Financing | 10.28M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.68M |
| Capital Expenditure | -249.00K |
| Issuance (Purchase) of Equity Shares | 10.28M |
| Net Cash Flow from Investing | -249.00K |
| Net Cash Flow from Operations | -3.34M |
| Share Based Compensation | 2.21M |